News
Dabigatran: Australia issues bleeding warning
Wed, Nov 9th 2011
The Australian regulatory authority, the Therapeutic Goods Administration (TGA), has issued a "safety advisory" on the new oral anticoagulant dabigatran.
Afib Ablation Boosts Kidney Function
Mon, Nov 7th 2011
MedPage Today
By Chris Kaiser, Cardiology Editor, MedPage Today Explain that a Japanese study found that patients with atrial fibrillation (AF) of any type who remained arrhythmia free at one year post ablation had improved kidney function compared to those whose AF ...
Read more
Xarelto (Rivaroxaban) Approved By FDA For Non-Valvular Atrial Fibrillation ...
Mon, Nov 7th 2011
Medical News Today
Xarelto (rivaroxaban), an anti-clotting medication, has been approved by the FDA for patients with non-valvular atrial fibrillation to reduce stroke risk. Xarelto, a Factor Xa inhibitor, acts at a crucial point in the blood-clotting process and stops ...
Read more
J&J Wins Blockbuster Approval to Market Xarelto for Stroke Prevention
Mon, Nov 7th 2011
DailyFinance
By Motley Fool Staff Posted 2:56PM 11/05/11 Investing The FDA has given Johnson & Johnson (NYS: JNJ) the green light to market Xarelto to prevent stroke among patients suffering from atrial fibrillation -- opening up a blockbuster market involving more ...
Read more
Dose Selection of New Oral Anticoagulants in Patients With Atrial Fibrillation: Factors That Matter Most
Mon, Nov 7th 2011
theheart.org
Drs. Lip and Connolly discuss factors to consider when determining eligibility and dosing for use of novel anticoagulants in patients with atrial fibrillation.
Read more
FDA broadens approval of J&J's Xarelto for patients with dangerous irregular ...
Mon, Nov 7th 2011
Washington Post
Federal health officials approved the drug from Johnson & Johnson and Bayer to prevent strokes in patients with atrial fibrillation, a condition that causes the heart's upper chambers beat chaotically and ineffectively. The irregular heartbeats can ...
Read more
New drug promising for patients with stroke risk
Fri, Nov 4th 2011
Vancouver Sun
The drug is used to prevent strokes in patients with atrial fibrillation, a heart rhythm disturbance associated with a four- to five-fold increased risk of ischemic stroke. Ezekowitz said the study, which included 1057 Canadians, was so promising that ...
Read more
Mayo Clinic Heart Specialists Use Cold Therapy to Treat Atrial Fibrillation
Fri, Nov 4th 2011
HealthCanal.com
More than 3 million people in the United States are estimated to suffer from atrial fibrillation, which can cause fast and chaotic heartbeat in people whose atria, or the upper chambers of the heart, receive irregular electrical current for no apparent ...
Read more
Atrial fibrillation goes unnoticed in over 65s
Fri, Nov 4th 2011
Barchester Healthcare
Some 67 per cent of people aged 65 and over are unable to recognise atrial fibrillation, according to a new survey. Approximately two-thirds of older adults cannot recognise the form of irregular heartbeat that is a warning sign of stroke, ...
Read more
FDA advisers reject Medtronic heart device
Fri, Nov 4th 2011
Reuters
N) device for treating atrial fibrillation, a heart rhythm disorder that is a major cause of stroke, citing risks to safety. A panel of outside experts for the Food and Drug Administration voted 8-2 that the risks of the Medtronic Cardiac Ablation ...
Read more
Dabigatran: Australia issues bleeding warning
Wed, Nov 2nd 2011
theheart.org
The Australian regulatory authority, the Therapeutic Goods Administration (TGA), has issued a "safety advisory" on the new oral anticoagulant dabigatran (Pradaxa, Boehringer Ingelheim) because of an increase in the number of bleeding-related adverse events reports received since more people starting taking the drug.
Read more
Cold Comfort
Mon, Oct 17th 2011
Maui News
But the Kihei woman recently had a portion of her heart frozen in a cutting-edge procedure to cure her irregular heartbeat, also known as atrial fibrillation. The condition had left her gasping for air doing such minor activities as walking to the ...
Read more
FDA Panel Endorses Xarelto for Stroke Prevention
Wed, Sep 14th 2011
abc/NEWS Health
A U.S. Food and Drug Administration advisory committee has voted 9-2, with one abstention, to recommend that the FDA approve the direct oral factor Xa inhibitor rivaroxaban (Xarelto) to prevent stroke in patients with a heart condition known as nonvalvular Atrial Fibrillation.
Read more
ESC: Apixaban beats out warfarin for preventing stroke, death
Sat, Sep 3rd 2011
Cardiovascular Business
The Xa inhibitor apixaban proved superior to warfarin in preventing stroke or systemic embolism in patients with atrial fibrillation (AF) while also reducing the risk of major bleeding and death by any cause, according to results of the ARISTOTLE trial ...
Read more
Examining The Causes of Atrial Fibrillation
Thu, Aug 25th 2011
Patch.com
One of the most common causes of an irregular heartbeat is a rhythm called atrial fibrillation (also called AF or a-fib). Affecting over two million Americans, AF is often related to other underlying illnesses, and may cause physical symptoms while ...
Read more
Bristol-Myers Squibb And Pfizer Announce Data Presentations For Apixaban At ...
Thu, Aug 25th 2011
MarketWatch (press release)
Globally-conducted registrational studies evaluating ELIQUIS for the prevention of stroke in patients with atrial fibrillation will be presented during the congress. Of note is the first presentation of the comprehensive analysis of ARISTOTLE (Apixaban ...
Read more
The determinants of stroke phenotypes were different from the predictors ...
Thu, Aug 25th 2011
7thSpace Interactive (press release)
Atrial fibrillation (AF) is a leading cause of fatal ischemic stroke. It was recently reported that international normalized ratio (INR) levels were associated with infarct volumes. However, factors other than INR levels that affect stroke phenotypes ...
Read more
Once-daily rivaroxaban appears to be as effective as dose-adjusted warfarin
Tue, Aug 23rd 2011
ModernMedicine
Once-daily oral rivaroxaban (Xarelto, Bayer), a direct factor Xa inhibitor, appears to be as effective as dose-adjusted warfarin in preventing stroke or major embolism in patients with nonvalvular atrial fibrillation, according to a study published ...
Read more
Group Health study finds higher dementia risk with atrial fibrillation
Mon, Aug 22nd 2011
News-Medical.net
The most common kind of chronically irregular heartbeat, known as atrial fibrillation, is associated with a greater risk of dementia, including Alzheimer's disease. This discovery by scientists at Group Health Research Institute and their collaborators ...
Read more
Obesity may trigger heart rhythm disturbance, atrial fibrillation
Mon, Aug 22nd 2011
eMaxHealth
Researcher suggests there is a direct link between obesity and the common heart rhythm disturbance atrial fibrillation in a first study. The finding comes from University of Adelaide scientists who found obesity triggers electrical abnormalities in the ...
Read more
Missing beats
Mon, Aug 22nd 2011
The Hindu
Four doctor visits and innumerable tests later, it emerged that Rakesh had a heart condition called atrial fibrillation. Rakesh is only one of a large number of people grappling with its debilitating effects. Atrial fibrillation is a condition that ...
Read more
A Roller coaster isn't the only thing that'll make your heart race
Mon, Aug 22nd 2011
PR Newswire (press release)
The Heart and Stroke Foundation urges you to stop by the "Be Pulse Aware" booth at the CNE (from August 19 to September 5, in the Direct Energy Centre, Hall A, booth #1308) to learn more about atrial fibrillation (AF) - because saving a life is as easy ...
Read more
Heart Patient Gets a Novel Wave of Laser Surgery
Mon, Aug 22nd 2011
TopNews United States
Scott Rosser, 34, suffered from a heart rhythm disorder named as atrial fibrillation which caused him to blackout, and also increased the risk of a stroke. British doctors used the laser balloon technique in which when it is pumped up inside the heart, ...
Read more
NICE asks for more information on new treatment for people with common heart condition
Mon, Aug 22nd 2011
Healthcare Today
In preliminary recommendations published today (Wednesday 17 August) NICE is asking Boehringer Ingelheim for more information on its product dabigatran (Pradaxa), for the prevention of stroke and systemic embolism in people with atrial fibrillation. ...
Read more
Proposal for new physiology-based AF classification is supported by AFNET and EHRA
Wed, Aug 17th 2011
REVEAL THE SILENT KILLERS AND LIVE LONGER: ONE HEART ONE LIFE CAMPAIGN
Wed, Aug 17th 2011
Response Source (press release)
To help reduce the incidence of stroke, Macclesfield based company, Dot Medical, has developed a brand new, non-invasive screening programme to check people for Atrial Fibrillation (irregular heartbeat) as well as 12 other heart measurements. ...
Read more
Atrial fibrillation: A matter of the heart
Wed, Aug 17th 2011
Asiaone Health
MALAYSIA - Patients with atrial fibrillation (AF) tend to have a more difficult time than other cardiac patients. This is because with present anticoagulation therapy, aside from restricting their diets, patient have to be monitored by a doctor frequently. Patients worry about becoming a burden to their families.
Read more
EC Approves BI's Pradaxa for Preventing Stroke in Atrial Fibrillation Patients
Wed, Aug 17th 2011
Genetic Engineering News
The European Commission cleared Boehringer Ingelheim's oral anticoagulant Pradaxa® (dabigatran etexilate) for preventing stroke in atrial fibrillation (AF) patients at risk of stroke. Equivalent approvals have previously been granted for the drug in ...
Read more
Cardiologist Urges Patients Using Multaq: Contact Physicians
Wed, Aug 17th 2011
Cape May County Herald (press release)
By Press Release COURT HOUSE — As a result of a Food and Drug Administration warning issued July 22 about the atrial fibrillation drug Multaq, cardiologist Dr. Suketu Nanavati has contacted at least 20 of his patients to stop taking the medicine and ...
Read more